

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.40125163 |
| 2 | digestion (GO:0007586) | 7.93495154 |
| 3 | angiotensin maturation (GO:0002003) | 7.81400824 |
| 4 | intestinal cholesterol absorption (GO:0030299) | 7.78346650 |
| 5 | cobalamin metabolic process (GO:0009235) | 7.31756852 |
| 6 | regulation of cellular extravasation (GO:0002691) | 7.29150808 |
| 7 | negative regulation of epidermal cell differentiation (GO:0045605) | 7.04685450 |
| 8 | antibacterial humoral response (GO:0019731) | 6.89925998 |
| 9 | antimicrobial humoral response (GO:0019730) | 6.59636001 |
| 10 | regulation of guanylate cyclase activity (GO:0031282) | 6.02538443 |
| 11 | transcytosis (GO:0045056) | 5.65163277 |
| 12 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.59999029 |
| 13 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.54252197 |
| 14 | negative regulation of epidermis development (GO:0045683) | 5.23896742 |
| 15 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 5.17847670 |
| 16 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 5.13069836 |
| 17 | NADH metabolic process (GO:0006734) | 4.95351557 |
| 18 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.89580280 |
| 19 | positive regulation of pseudopodium assembly (GO:0031274) | 4.80816294 |
| 20 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.69260098 |
| 21 | glycolipid catabolic process (GO:0019377) | 4.58362277 |
| 22 | positive regulation of respiratory burst (GO:0060267) | 4.53154985 |
| 23 | regulation of pseudopodium assembly (GO:0031272) | 4.32306082 |
| 24 | digestive system process (GO:0022600) | 4.30311506 |
| 25 | ceramide catabolic process (GO:0046514) | 4.25772997 |
| 26 | regulation of keratinocyte differentiation (GO:0045616) | 4.19869905 |
| 27 | regulation of bile acid biosynthetic process (GO:0070857) | 4.18655775 |
| 28 | regulation of keratinocyte proliferation (GO:0010837) | 4.09620463 |
| 29 | regulation of phospholipase A2 activity (GO:0032429) | 4.09302524 |
| 30 | epithelial structure maintenance (GO:0010669) | 4.03793009 |
| 31 | membrane lipid catabolic process (GO:0046466) | 4.02815811 |
| 32 | peptide catabolic process (GO:0043171) | 3.95772067 |
| 33 | icosanoid secretion (GO:0032309) | 3.94886820 |
| 34 | arachidonic acid secretion (GO:0050482) | 3.94886820 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 3.92204188 |
| 36 | innate immune response in mucosa (GO:0002227) | 3.91505382 |
| 37 | peptide hormone processing (GO:0016486) | 3.85447812 |
| 38 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.74087402 |
| 39 | icosanoid transport (GO:0071715) | 3.73192140 |
| 40 | fatty acid derivative transport (GO:1901571) | 3.73192140 |
| 41 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.67145791 |
| 42 | endocrine process (GO:0050886) | 3.67145791 |
| 43 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.67145791 |
| 44 | fructose metabolic process (GO:0006000) | 3.63638465 |
| 45 | regulation of cGMP biosynthetic process (GO:0030826) | 3.62947581 |
| 46 | hormone catabolic process (GO:0042447) | 3.60126269 |
| 47 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.57918611 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57843439 |
| 49 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.52346087 |
| 50 | diacylglycerol metabolic process (GO:0046339) | 3.50959379 |
| 51 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.50292509 |
| 52 | sphingolipid catabolic process (GO:0030149) | 3.49279431 |
| 53 | acute-phase response (GO:0006953) | 3.48766695 |
| 54 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.47943836 |
| 55 | phosphatidylserine metabolic process (GO:0006658) | 3.47628900 |
| 56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44395526 |
| 57 | lipoprotein transport (GO:0042953) | 3.43192810 |
| 58 | regulation of systemic arterial blood pressure (GO:0003073) | 3.42625683 |
| 59 | epoxygenase P450 pathway (GO:0019373) | 3.41966095 |
| 60 | complement activation, classical pathway (GO:0006958) | 3.39102449 |
| 61 | urea cycle (GO:0000050) | 3.39003594 |
| 62 | glomerular filtration (GO:0003094) | 3.38279251 |
| 63 | glucuronate metabolic process (GO:0019585) | 3.32989787 |
| 64 | uronic acid metabolic process (GO:0006063) | 3.32989787 |
| 65 | cellular glucuronidation (GO:0052695) | 3.32281225 |
| 66 | leukotriene metabolic process (GO:0006691) | 3.30940707 |
| 67 | cellular response to cadmium ion (GO:0071276) | 3.28831424 |
| 68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26423441 |
| 69 | phosphatidic acid biosynthetic process (GO:0006654) | 3.25855540 |
| 70 | phosphatidic acid metabolic process (GO:0046473) | 3.25855540 |
| 71 | mucosal immune response (GO:0002385) | 3.25760504 |
| 72 | arginine metabolic process (GO:0006525) | 3.24997615 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24314946 |
| 74 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.23882114 |
| 75 | doxorubicin metabolic process (GO:0044598) | 3.18290044 |
| 76 | daunorubicin metabolic process (GO:0044597) | 3.18290044 |
| 77 | polyketide metabolic process (GO:0030638) | 3.18290044 |
| 78 | glycoside metabolic process (GO:0016137) | 3.14766732 |
| 79 | urea metabolic process (GO:0019627) | 3.13178843 |
| 80 | alditol phosphate metabolic process (GO:0052646) | 3.13131629 |
| 81 | vitamin A metabolic process (GO:0006776) | 3.12541569 |
| 82 | adhesion of symbiont to host cell (GO:0044650) | 3.11583674 |
| 83 | virion attachment to host cell (GO:0019062) | 3.11583674 |
| 84 | renal filtration (GO:0097205) | 3.08277189 |
| 85 | leukotriene biosynthetic process (GO:0019370) | 3.07558775 |
| 86 | glycosphingolipid catabolic process (GO:0046479) | 3.07436980 |
| 87 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.07074762 |
| 88 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.04260200 |
| 89 | organ or tissue specific immune response (GO:0002251) | 3.00916370 |
| 90 | cyclooxygenase pathway (GO:0019371) | 3.00360275 |
| 91 | regulation of cGMP metabolic process (GO:0030823) | 2.95303122 |
| 92 | regulation of cholesterol homeostasis (GO:2000188) | 2.95026252 |
| 93 | regulation of respiratory burst (GO:0060263) | 2.94769634 |
| 94 | GDP-mannose metabolic process (GO:0019673) | 2.93804211 |
| 95 | eosinophil chemotaxis (GO:0048245) | 2.92506248 |
| 96 | negative regulation of hormone metabolic process (GO:0032351) | 2.91074672 |
| 97 | arginine catabolic process (GO:0006527) | 2.90215554 |
| 98 | regulation of triglyceride catabolic process (GO:0010896) | 2.87806547 |
| 99 | nitrogen cycle metabolic process (GO:0071941) | 2.86134430 |
| 100 | regulation of necrotic cell death (GO:0010939) | 2.83478197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.43813346 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.28793162 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.59825169 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.49229786 |
| 5 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.27222832 |
| 6 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.15570292 |
| 7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.04622702 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.93583765 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.72414051 |
| 10 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.61402032 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.58002663 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38419676 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32438322 |
| 14 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.16950290 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16668984 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.13426700 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.11482736 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.10516000 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.03997322 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99702017 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.93606101 |
| 22 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.91650052 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87317292 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86298607 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.76708521 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74879794 |
| 27 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.74165491 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.73925868 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.73470907 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72932063 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.65661299 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60261140 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58660725 |
| 34 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.55415263 |
| 35 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.54421192 |
| 36 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.46107806 |
| 37 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45543607 |
| 38 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.39618583 |
| 39 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.38621416 |
| 40 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38166281 |
| 41 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36729669 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34164542 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33912827 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.33517233 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31274610 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30938219 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28788137 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28466385 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26928090 |
| 50 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23359453 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21943001 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20836199 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20824640 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19827171 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06499653 |
| 56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06193549 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.05437240 |
| 58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05402089 |
| 59 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04500923 |
| 60 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03907694 |
| 61 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03845628 |
| 62 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02947177 |
| 63 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02353165 |
| 64 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02118871 |
| 65 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.00725203 |
| 66 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00341488 |
| 67 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99651578 |
| 68 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98822835 |
| 69 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98822835 |
| 70 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98822835 |
| 71 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98601426 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97219965 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96254245 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96057811 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93588210 |
| 76 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93259673 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91397191 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89940621 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88269317 |
| 80 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.87546838 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86566715 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86489049 |
| 83 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.82700746 |
| 84 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82655995 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.82045673 |
| 86 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81584655 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78318747 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77986400 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77480103 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76005006 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75867634 |
| 92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.75493846 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74683068 |
| 94 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.74276711 |
| 95 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.73845777 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73717706 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73559040 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72769580 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72034727 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.70547706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001666_abnormal_nutrient_absorption | 7.39590627 |
| 2 | MP0005360_urolithiasis | 5.86725549 |
| 3 | MP0005365_abnormal_bile_salt | 4.49847283 |
| 4 | MP0003868_abnormal_feces_composition | 4.35764155 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.39381631 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.37897177 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.27781917 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.06151656 |
| 9 | MP0010155_abnormal_intestine_physiology | 2.90341542 |
| 10 | MP0001873_stomach_inflammation | 2.71267936 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.65535651 |
| 12 | MP0009840_abnormal_foam_cell | 2.57489775 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.41522712 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.41246393 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.31669187 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.27181471 |
| 17 | MP0003866_abnormal_defecation | 2.22618547 |
| 18 | MP0004858_abnormal_nervous_system | 2.14660952 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.02136909 |
| 20 | MP0001664_abnormal_digestion | 1.96760607 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.80451665 |
| 22 | MP0005166_decreased_susceptibility_to | 1.80221855 |
| 23 | MP0004782_abnormal_surfactant_physiolog | 1.77474848 |
| 24 | MP0004147_increased_porphyrin_level | 1.72919887 |
| 25 | MP0005409_darkened_coat_color | 1.65434477 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.58011626 |
| 27 | MP0005332_abnormal_amino_acid | 1.54863191 |
| 28 | MP0000490_abnormal_crypts_of | 1.51464862 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.47250673 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.45506662 |
| 31 | MP0005448_abnormal_energy_balance | 1.43244560 |
| 32 | MP0000678_abnormal_parathyroid_gland | 1.41763182 |
| 33 | MP0000462_abnormal_digestive_system | 1.40682250 |
| 34 | MP0001663_abnormal_digestive_system | 1.40160734 |
| 35 | MP0003436_decreased_susceptibility_to | 1.36488999 |
| 36 | MP0000477_abnormal_intestine_morphology | 1.32699330 |
| 37 | MP0003724_increased_susceptibility_to | 1.31390328 |
| 38 | MP0003329_amyloid_beta_deposits | 1.27959419 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.26967515 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.26527199 |
| 41 | MP0001756_abnormal_urination | 1.26425252 |
| 42 | MP0003959_abnormal_lean_body | 1.21765779 |
| 43 | MP0000538_abnormal_urinary_bladder | 1.21418807 |
| 44 | MP0005381_digestive/alimentary_phenotyp | 1.19109495 |
| 45 | MP0003252_abnormal_bile_duct | 1.17287155 |
| 46 | MP0005387_immune_system_phenotype | 1.14959444 |
| 47 | MP0001790_abnormal_immune_system | 1.14959444 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.10720141 |
| 49 | MP0009785_altered_susceptibility_to | 1.10433727 |
| 50 | MP0008004_abnormal_stomach_pH | 1.01715818 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.01018799 |
| 52 | MP0002136_abnormal_kidney_physiology | 0.99921079 |
| 53 | MP0002796_impaired_skin_barrier | 0.99222042 |
| 54 | MP0005025_abnormal_response_to | 0.96778053 |
| 55 | MP0002166_altered_tumor_susceptibility | 0.96684556 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 0.93366597 |
| 57 | MP0000604_amyloidosis | 0.92942931 |
| 58 | MP0001764_abnormal_homeostasis | 0.91929495 |
| 59 | MP0004043_abnormal_pH_regulation | 0.91009269 |
| 60 | MP0001533_abnormal_skeleton_physiology | 0.90658024 |
| 61 | MP0002822_catalepsy | 0.86013845 |
| 62 | MP0001501_abnormal_sleep_pattern | 0.85931369 |
| 63 | MP0002693_abnormal_pancreas_physiology | 0.85245391 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 0.84626955 |
| 65 | MP0001835_abnormal_antigen_presentation | 0.84140545 |
| 66 | MP0008469_abnormal_protein_level | 0.84025377 |
| 67 | MP0003075_altered_response_to | 0.82951799 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.81026123 |
| 69 | MP0001188_hyperpigmentation | 0.80724650 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.80477059 |
| 71 | MP0003879_abnormal_hair_cell | 0.79804480 |
| 72 | MP0004947_skin_inflammation | 0.76861400 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.76689243 |
| 74 | MP0001881_abnormal_mammary_gland | 0.75721546 |
| 75 | MP0002909_abnormal_adrenal_gland | 0.75288849 |
| 76 | MP0005671_abnormal_response_to | 0.73962972 |
| 77 | MP0000537_abnormal_urethra_morphology | 0.72245448 |
| 78 | MP0002098_abnormal_vibrissa_morphology | 0.71756492 |
| 79 | MP0000609_abnormal_liver_physiology | 0.71401641 |
| 80 | MP0004270_analgesia | 0.70780247 |
| 81 | MP0002896_abnormal_bone_mineralization | 0.69104107 |
| 82 | MP0005334_abnormal_fat_pad | 0.69005312 |
| 83 | MP0000685_abnormal_immune_system | 0.68846595 |
| 84 | MP0003953_abnormal_hormone_level | 0.67352694 |
| 85 | MP0006082_CNS_inflammation | 0.66939427 |
| 86 | MP0003045_fibrosis | 0.65588192 |
| 87 | MP0002006_tumorigenesis | 0.63939066 |
| 88 | MP0002971_abnormal_brown_adipose | 0.63189965 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.63075017 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.61836305 |
| 91 | MP0002148_abnormal_hypersensitivity_rea | 0.60061784 |
| 92 | MP0005165_increased_susceptibility_to | 0.60039886 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.59746369 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 0.59279978 |
| 95 | MP0000681_abnormal_thyroid_gland | 0.58908263 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.58554248 |
| 97 | MP0009764_decreased_sensitivity_to | 0.58427014 |
| 98 | MP0005000_abnormal_immune_tolerance | 0.57549876 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.57290570 |
| 100 | MP0005452_abnormal_adipose_tissue | 0.56598895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 9.79936555 |
| 2 | Fat malabsorption (HP:0002630) | 9.15855491 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.14643568 |
| 4 | Malnutrition (HP:0004395) | 6.41759875 |
| 5 | Exocrine pancreatic insufficiency (HP:0001738) | 6.06448772 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 5.58375719 |
| 7 | Hydroxyprolinuria (HP:0003080) | 5.58375719 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.26754069 |
| 9 | Pancreatitis (HP:0001733) | 5.10009230 |
| 10 | Ileus (HP:0002595) | 4.73819256 |
| 11 | Hypoproteinemia (HP:0003075) | 4.54282428 |
| 12 | Chronic diarrhea (HP:0002028) | 4.20943419 |
| 13 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.79212659 |
| 14 | Abnormality of vitamin B metabolism (HP:0004340) | 3.62930623 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.54511917 |
| 16 | Glomerulonephritis (HP:0000099) | 3.51072380 |
| 17 | Villous atrophy (HP:0011473) | 3.48231828 |
| 18 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.48231828 |
| 19 | Hyperphosphatemia (HP:0002905) | 3.13845579 |
| 20 | Abnormality of vitamin metabolism (HP:0100508) | 3.04474180 |
| 21 | Complement deficiency (HP:0004431) | 3.02860671 |
| 22 | Congenital sensorineural hearing impairment (HP:0008527) | 3.00287971 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.97141826 |
| 24 | Abnormality of complement system (HP:0005339) | 2.94519356 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.91846716 |
| 26 | Glycosuria (HP:0003076) | 2.89510939 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 2.89510939 |
| 28 | Acanthocytosis (HP:0001927) | 2.83333740 |
| 29 | Hyperparathyroidism (HP:0000843) | 2.80673670 |
| 30 | Abnormality of the pleura (HP:0002103) | 2.76625666 |
| 31 | Nephritis (HP:0000123) | 2.74418558 |
| 32 | Widely patent fontanelles and sutures (HP:0004492) | 2.72941451 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 2.63105531 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 2.58629014 |
| 35 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.54662435 |
| 36 | Nausea (HP:0002018) | 2.53547763 |
| 37 | Symptomatic seizures (HP:0011145) | 2.48470016 |
| 38 | Decreased circulating renin level (HP:0003351) | 2.48009151 |
| 39 | Proximal tubulopathy (HP:0000114) | 2.47378390 |
| 40 | Hyperammonemia (HP:0001987) | 2.45540736 |
| 41 | Hypophosphatemia (HP:0002148) | 2.41305492 |
| 42 | Abdominal distention (HP:0003270) | 2.36753195 |
| 43 | Alkalosis (HP:0001948) | 2.31735250 |
| 44 | Nephrolithiasis (HP:0000787) | 2.31330078 |
| 45 | Hyperuricemia (HP:0002149) | 2.30560971 |
| 46 | Increased purine levels (HP:0004368) | 2.30560971 |
| 47 | Hypotension (HP:0002615) | 2.25670342 |
| 48 | Rectal prolapse (HP:0002035) | 2.22617145 |
| 49 | Facial shape deformation (HP:0011334) | 2.20310338 |
| 50 | Potter facies (HP:0002009) | 2.20310338 |
| 51 | Xanthomatosis (HP:0000991) | 2.18251154 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18115812 |
| 53 | Abnormality of renin-angiotensin system (HP:0000847) | 2.14666147 |
| 54 | Metabolic alkalosis (HP:0200114) | 2.14107221 |
| 55 | Gout (HP:0001997) | 2.12666241 |
| 56 | Wide cranial sutures (HP:0010537) | 2.10218604 |
| 57 | Hyperactive renin-angiotensin system (HP:0000841) | 2.09667467 |
| 58 | Late onset (HP:0003584) | 2.09531835 |
| 59 | Posterior subcapsular cataract (HP:0007787) | 2.08415088 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.07350560 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.06943056 |
| 62 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06943056 |
| 63 | Confusion (HP:0001289) | 2.05360559 |
| 64 | Hyperglycinuria (HP:0003108) | 2.02037206 |
| 65 | Gastrointestinal dysmotility (HP:0002579) | 2.01390214 |
| 66 | Hyperphosphaturia (HP:0003109) | 2.01342364 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.00815429 |
| 68 | Focal segmental glomerulosclerosis (HP:0000097) | 2.00219606 |
| 69 | Dicarboxylic aciduria (HP:0003215) | 1.98540727 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98540727 |
| 71 | Vascular calcification (HP:0004934) | 1.98234235 |
| 72 | Growth hormone excess (HP:0000845) | 1.95958688 |
| 73 | Thin bony cortex (HP:0002753) | 1.95281564 |
| 74 | Abnormal glucose tolerance (HP:0001952) | 1.93939573 |
| 75 | Abdominal pain (HP:0002027) | 1.91908921 |
| 76 | Hypoglycemic seizures (HP:0002173) | 1.90370479 |
| 77 | Abnormal biliary tract morphology (HP:0012440) | 1.88749469 |
| 78 | Cerebral palsy (HP:0100021) | 1.85913432 |
| 79 | Hypoglycemic coma (HP:0001325) | 1.84589298 |
| 80 | Gingivitis (HP:0000230) | 1.84171848 |
| 81 | Renal tubular acidosis (HP:0001947) | 1.83795802 |
| 82 | Abnormality of nucleobase metabolism (HP:0010932) | 1.83543046 |
| 83 | Abnormal urine phosphate concentration (HP:0012599) | 1.80383917 |
| 84 | Megaloblastic anemia (HP:0001889) | 1.79565803 |
| 85 | Metabolic acidosis (HP:0001942) | 1.77960224 |
| 86 | Goiter (HP:0000853) | 1.74686838 |
| 87 | Abnormality of magnesium homeostasis (HP:0004921) | 1.73855658 |
| 88 | Ventricular fibrillation (HP:0001663) | 1.73761084 |
| 89 | Cardiovascular calcification (HP:0011915) | 1.73694938 |
| 90 | Tetraparesis (HP:0002273) | 1.68880314 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.68830407 |
| 92 | Protuberant abdomen (HP:0001538) | 1.68815549 |
| 93 | Gastrointestinal stroma tumor (HP:0100723) | 1.67869283 |
| 94 | Bone pain (HP:0002653) | 1.67742018 |
| 95 | Pili torti (HP:0003777) | 1.65073366 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 1.63896812 |
| 97 | Rhabdomyolysis (HP:0003201) | 1.63420884 |
| 98 | Petechiae (HP:0000967) | 1.63299574 |
| 99 | Glomerulosclerosis (HP:0000096) | 1.62281435 |
| 100 | Hypoalbuminemia (HP:0003073) | 1.62159556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.76658334 |
| 2 | ACVR1B | 4.60027401 |
| 3 | MST1R | 4.47790881 |
| 4 | LMTK2 | 3.99352416 |
| 5 | PRKG2 | 3.42512939 |
| 6 | RIPK1 | 3.37467757 |
| 7 | EPHA3 | 3.21255805 |
| 8 | PDK2 | 3.08345664 |
| 9 | FGFR4 | 2.86944188 |
| 10 | EPHA2 | 2.77824334 |
| 11 | MAP3K12 | 2.43590535 |
| 12 | STK39 | 2.34871802 |
| 13 | EPHB1 | 2.30494738 |
| 14 | TYK2 | 2.01032052 |
| 15 | OXSR1 | 1.89938654 |
| 16 | STK24 | 1.69683080 |
| 17 | MAP3K10 | 1.67421705 |
| 18 | MET | 1.58367753 |
| 19 | NLK | 1.56299374 |
| 20 | FGFR3 | 1.53129103 |
| 21 | EPHB2 | 1.46962918 |
| 22 | MAP3K1 | 1.44319401 |
| 23 | MYLK | 1.39223031 |
| 24 | TESK1 | 1.31503674 |
| 25 | MAP3K2 | 1.31093557 |
| 26 | IRAK1 | 1.26226056 |
| 27 | FER | 1.25147482 |
| 28 | PTK6 | 1.24344596 |
| 29 | MST4 | 1.16447641 |
| 30 | JAK1 | 1.14961347 |
| 31 | DDR2 | 1.12808877 |
| 32 | PRPF4B | 1.11857475 |
| 33 | TESK2 | 1.09600857 |
| 34 | MAP4K1 | 1.07903184 |
| 35 | TGFBR2 | 1.06199212 |
| 36 | MAP3K14 | 1.04801555 |
| 37 | CDC42BPA | 1.01550283 |
| 38 | MAP3K3 | 1.01536172 |
| 39 | GRK6 | 1.00299686 |
| 40 | RIPK4 | 0.97962740 |
| 41 | GRK1 | 0.93486458 |
| 42 | MATK | 0.89261127 |
| 43 | PDPK1 | 0.87508561 |
| 44 | TBK1 | 0.87116616 |
| 45 | BMPR2 | 0.86759775 |
| 46 | MAP2K2 | 0.84189197 |
| 47 | ZAP70 | 0.77994203 |
| 48 | KIT | 0.75214680 |
| 49 | IKBKE | 0.71965546 |
| 50 | TAOK1 | 0.70792477 |
| 51 | PIK3CA | 0.69419544 |
| 52 | NEK6 | 0.67797106 |
| 53 | PDGFRA | 0.65409610 |
| 54 | ERBB2 | 0.63638153 |
| 55 | TNIK | 0.60441031 |
| 56 | JAK3 | 0.60413591 |
| 57 | PAK4 | 0.58140198 |
| 58 | PDK1 | 0.57379356 |
| 59 | EIF2AK3 | 0.54091716 |
| 60 | JAK2 | 0.52959902 |
| 61 | BMX | 0.51462588 |
| 62 | PRKACG | 0.48813260 |
| 63 | MAP2K6 | 0.48285980 |
| 64 | PRKCA | 0.47054451 |
| 65 | LRRK2 | 0.45976106 |
| 66 | CSK | 0.45000939 |
| 67 | DAPK2 | 0.44774074 |
| 68 | RET | 0.44051145 |
| 69 | PRKCQ | 0.43355545 |
| 70 | CASK | 0.42826341 |
| 71 | MAP3K11 | 0.42245620 |
| 72 | YES1 | 0.40163654 |
| 73 | STK16 | 0.39817877 |
| 74 | SRC | 0.39319735 |
| 75 | PTK2 | 0.37488055 |
| 76 | IRAK4 | 0.36095506 |
| 77 | MAPK11 | 0.35200965 |
| 78 | HIPK2 | 0.35061253 |
| 79 | CDK19 | 0.34737744 |
| 80 | FYN | 0.32940231 |
| 81 | PRKAA2 | 0.31372928 |
| 82 | TAOK3 | 0.31094131 |
| 83 | PRKCD | 0.30769467 |
| 84 | PRKCZ | 0.30636336 |
| 85 | PASK | 0.29512592 |
| 86 | MELK | 0.28789586 |
| 87 | KSR2 | 0.26488607 |
| 88 | CSF1R | 0.26331398 |
| 89 | IGF1R | 0.25762690 |
| 90 | ERBB3 | 0.25546462 |
| 91 | MAPK7 | 0.22700252 |
| 92 | DAPK1 | 0.21961569 |
| 93 | ABL2 | 0.21751529 |
| 94 | CAMK2D | 0.21522146 |
| 95 | DAPK3 | 0.20374673 |
| 96 | PDGFRB | 0.20138943 |
| 97 | ROCK1 | 0.20085165 |
| 98 | LYN | 0.20029515 |
| 99 | PRKCE | 0.18918180 |
| 100 | IRAK3 | 0.17571897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.77613318 |
| 2 | Pancreatic secretion_Homo sapiens_hsa04972 | 4.73315157 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 4.26791496 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.74112492 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.49620533 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.33099583 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.56422420 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.41309197 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.17937615 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04860057 |
| 11 | Mineral absorption_Homo sapiens_hsa04978 | 2.04793310 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93403724 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.82631375 |
| 14 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.73954317 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72605222 |
| 16 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.68137952 |
| 17 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.55114788 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.52649051 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.50264651 |
| 20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.47641835 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44596373 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42484218 |
| 23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40942358 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35907241 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26631881 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24226594 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.22404550 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20487512 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19986395 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.18304853 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16686279 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.15852524 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08507946 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07518464 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05928399 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05259486 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.03282365 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99315009 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97487441 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 0.96252427 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95540876 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93254481 |
| 43 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91447363 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.90728812 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.90633239 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82890227 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81580899 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80277885 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74529945 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62490105 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62263246 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62157825 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58980461 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58412947 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56984773 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 0.56381271 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.54711663 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53198759 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50432976 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49710835 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49534172 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47065583 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41443595 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.40618482 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39273373 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36263841 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36040366 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.35668509 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.33889207 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30964999 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30135293 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29533313 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29060803 |
| 74 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28687589 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.26334555 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25501783 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.23945748 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23263613 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.21030617 |
| 80 | Tight junction_Homo sapiens_hsa04530 | 0.19506860 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.17941377 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.17909998 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.16364539 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.16087755 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.14629278 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.12219523 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12070302 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10297726 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.10220977 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.10039723 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.09708635 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09633656 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.09141921 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.08760576 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.08579349 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.07920127 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.06870883 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.05883643 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.04912106 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04048607 |

